CTRI/2018/05/013754招募中未知
A Retrospective Safety Data Collection Registry of VivitraTM (Trastuzumab) - VivitraTM Registry
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patient should have completed the 4 cycle of VivitraTM treatment on the approved indications
排除标准
- •Any reason which may prevent the doctor to enroll the patient in the registry.
研究者
相似试验
进行中（未招募）
1 期
ong-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trialsMultiple Sclerosis patients who have participated in cladribine tablets clinical trialsMedDRA version: 20.1 Level: PT Classification code 10028245 Term: Multiple sclerosis System Organ Class: 10029205 - Nervous system disordersEUCTR2009-017978-21-DEMerck Serono S.A. - Geneva1,148
进行中（未招募）
1 期
ong-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trialsMultiple Sclerosis patients who have participated in cladribine tablets clinical trialsMedDRA version: 14.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersEUCTR2009-017978-21-ITMERCK SERONO SA1,148
进行中（未招募）
1 期
ong-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trialsEUCTR2009-017978-21-EEMerck Serono S.A. - Geneva2,175
进行中（未招募）
1 期
ong-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trialsEUCTR2009-017978-21-BEMerck Serono S.A. - Geneva1,148
进行中（未招募）
1 期
ong-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trialsEUCTR2009-017978-21-LVMerck Serono S.A. - Geneva2,175